Head and Neck Cancer: Relationship of the Prechemotherapy Serum Alkaline Phosphatase Levels to Response Rate of Induction Chemotherapy
- 1 January 1982
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 108 (1) , 28-29
- https://doi.org/10.1001/archotol.1982.00790490030007
Abstract
• Fifty-one patients with stage III or IV squamous cell carcinoma of the head and neck who received induction chemotherapy with cisplatin and bleomycin sulfate with and without high-dose methotrexate were studied. The relationship of the prechemotherapy levels of serum alkaline phosphatase, lactic dehydrogenase, SGOT, SGPT, BUN, creatinine, calcium, total protein, albumin, hemoglobin, uric acid, and bilirubin and the WBC and platelet counts was correlated with the response rate. The overall response rate was 65%. No notable relationship between any of the laboratory values and the response rate was found. In contrast to an earlier report, patients with a low alkaline phosphatase level responded as well as patients with an elevated serum alkaline phosphatase level. (Arch Otolaryngol 1982;108:28-29)This publication has 4 references indexed in Scilit:
- The chemotherapy of head and neck cancerAnti-Cancer Drugs, 1999
- Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancerCancer, 1979
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- The prediction of tumor regression in human squamous carcinoma by means of the potential tumor doubling timeCancer, 1977